Targeted therapy in CLL: changing the treatment paradigm

Oncotarget. 2019 Jun 18;10(40):4002-4003. doi: 10.18632/oncotarget.26964.
No abstract available

Keywords: BCL2; TP53; chronic lymphocytic leukemia; deletion 17p; venetoclax.

Publication types

  • Editorial